Abstract
Background
When the COVID-19 pandemic was declared, Yemen, a country facing years of conflict had only one laboratory with PCR testing capacity. In this article, we describe the outcome of the implementation of molecular based diagnostics platform in Yemen and highlight the key milestones the country went through to increase access to testing for its populations residing in a geographically vast and politically divided country.
Methods
A retrospective assessment of COVID-19 laboratory response activities was done detailing the needs assessment process, timelines, geographical coverage, and outcomes of the activities. Laboratory data was analyzed to construct the geographical locations of COVID-19 testing laboratories and the numbers of tests performed in each facility to highlight the demands of testing for travelers. Finally, we discuss the impact these activities had in enabling the movement of people across international borders for economic gains and in delivery of critical humanitarian aid.
Outcome
PCR testing capacities in Yemen significantly improved, from one laboratory in Sanaa in April 2020 to 18 facilities across the country by June 2022. In addition, the number of functional Real-Time PCR thermocyclers increased from one to 32, the PCR tests output per day improved from 192 to 6144 tests per day. Results from analysis of laboratory data showed there were four peaks of COVID-19 in Yemen as October 2022. The majority of laboratory tests were performed for travelers than for medical or public health reasons. Demand for laboratory testing in Yemen was generally low and waned over time as the perceived risk of COVID-19 declined, in parallel with rollout of the COVID-19 vaccines.
Discussion/Conclusion
The successful expansion of laboratory testing capacity was instrumental in the control and management of COVID-19 cases and critical in the implementation of public response strategies, including restrictions on gathering. Laboratory testing also facilitated the movement of humanitarian agencies and delivery of aid and enabled hundreds of thousands of Yemeni nationals to travel internationally. By virtue of these outcomes, the impact of laboratory strengthening activities was thus felt in the health sector and beyond.
Publisher
Public Library of Science (PLoS)
Reference21 articles.
1. The Lancet Commission on diagnostics: transforming access to diagnostics;KA Fleming;The Lancet,2021
2. World Health Organization—Diagnostic testing for SARS-CoV-2: Interim guidance:https://apps.who.int/iris/bitstream/handle/10665/334254/WHO-2019-nCoV-laboratory-2020.6-eng.pdf?sequence=1&isAllowed=y accessed 01/05/2023.
3. Primer design for quantitative real-time PCR for the emerging Coronavirus SARS-CoV-2;D Li;Theranostics,2020
4. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR;VM Corman;Eurosurveillance,2020
5. World Health Organization—Laboratory assessment tool: 1 April 2012, WHO/HSE/GCR/LYO/2012.2 https://www.who.int/publications/i/item/WHO-HSE-GCR-LYO-2012.2: https://www.who.int/publications/i/item/WHO-HSE-GCR-LYO-2012.2—accessed on 02/05/2023.